Project 1 - Molecular structure and function
项目1——分子结构与功能
基本信息
- 批准号:10628928
- 负责人:
- 金额:$ 63.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAge related macular degenerationAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease patientAmyloid beta-ProteinAtrophicBasal laminaBindingBinding ProteinsBiological AssayBlindnessBloodBlood capillariesBone remodelingBrainBruch&aposs basal membrane structureCaliforniaCell AdhesionCell NucleusCell modelCellsChemicalsChoroidComplementDataDepositionDevelopmentDiseaseDisease ProgressionDisease modelDrusenExtracellular MatrixEyeFluorescenceGlycoproteinsGoalsHemostatic functionHydroxyapatitesHydroxylationIn VitroInvestigationLengthLinkLipidsMedicalMineralsModelingMolecularMolecular StructureNMR SpectroscopyNatural ImmunityNeuronsNuclear Magnetic ResonancePathologicProcessPropertyProteinsResolutionRetinaRisk FactorsRoleSamplingSenile PlaquesSolidSpecificityStructureStructure of retinal pigment epitheliumSurfaceTestingTherapeutic AgentsTissuesUniversitiesVariantVitronectinbiophysical techniquescalcificationcalcification inhibitorcalcium phosphatecell motilitycomplex biological systemsexperimental studyextracellularmineralizationnovel diagnosticsnovel therapeuticsreconstitutionsensorsmall moleculesolid state nuclear magnetic resonancetau Proteinstrait
项目摘要
PROJECT 1 SUMMARY
Molecular structure and function. The ectopic accumulation of mineralized calcium-phosphate deposits in
the eye and brain is a hallmark of Age-Related Macular Degeneration (AMD) and Alzheimer’s Disease (AD). In
addition to inorganic components, such as hydroxyapatite (HAP), these deposits also contain lipids and
proteins of both blood and intracellular origin. The process of calcification is poorly understood, and it remains
unclear why some deposits progress to the disease state while others do not. It is also not clear if the
associated proteins are involved in the mineralization process, or if they deposit and accumulate on the already
pre-formed hydroxyapatite surface. Here, we address these important questions by comprehensive and
systematic investigation of the chemical, physical and structural properties of the molecular components
associated with calcified deposits, with particular focus on three validated constituents: the proteins vitronectin
(Vn), amyloid-b (Ab) and Tau. Vn is a blood glycoprotein with diverse functions in hemostasis, cell adhesion
and migration, innate immunity, tissue and bone remodeling. Recent studies have indicated that Vn binds both
soluble Ca2+ and solid HAP with chemical specificity and the T400M Vn variant is a major risk factor for AMD.
Ab and Tau are well known components of amyloid plaques in AD, but they are also found in calcification
deposits in the eye and the brain. First, we will investigate the role of these proteins in the calcification process
through fluorescence-based experiments and binding studies. Then, we will reconstitute proto-aggregates of
HAP, lipids and proteins to model pathological deposit formation in vitro. These aggregates will provide a
platform for assaying the functional roles of proteins and lipids in calcification and will aid the discovery of small
molecule and biomolecular inhibitors of calcification. And finally, we will use solid-state nuclear magnetic
resonance (NMR) spectroscopy to determine the structures of Vn, Tau and Ab within calcified deposits and to
describe the protein-mineral interactions that drive their assembly. This information will be essential for
understanding the molecular mechanism of calcification and, ultimately, for the development of new diagnostic
and therapeutic agents.
项目1概要
分子结构和功能。矿化钙磷矿床的异位堆积
眼睛和大脑的损害是视网膜相关性黄斑变性(AMD)和阿尔茨海默病(AD)的标志。在
除了无机组分如羟基磷灰石(HAP)之外,这些沉积物还含有脂质,
血液和细胞内来源的蛋白质。钙化的过程知之甚少,
不清楚为什么有些沉积物进展到疾病状态,而另一些则没有。目前还不清楚,
相关的蛋白质参与矿化过程,或者如果它们存款和积累在已经
预成型的羟基磷灰石表面。在这里,我们通过全面和
系统研究分子组分的化学、物理和结构特性
与钙化沉积物相关,特别关注三种经验证的成分:
(Vn)、淀粉样蛋白-b(Ab)和Tau. VN是一种血液糖蛋白,具有止血、细胞粘附、细胞增殖、细胞凋亡等多种功能
和迁移、先天免疫、组织和骨骼重塑。最近的研究表明,Vn结合了
具有化学特异性的可溶性Ca 2+和固体HAP以及T400 M Vn变体是AMD的主要危险因素。
Ab和Tau是AD中淀粉样斑块的已知组分,但它们也在钙化中发现,
沉积在眼睛和大脑里首先,我们将研究这些蛋白质在钙化过程中的作用
通过基于荧光的实验和结合研究。然后,我们将重建原始聚集体,
HAP、脂质和蛋白质以模拟体外病理性存款形成。这些聚合物将提供
该平台用于测定蛋白质和脂质在钙化中的功能作用,并将有助于发现小的
钙化的分子和生物分子抑制剂。最后,我们将使用固态核磁共振
共振(NMR)光谱以确定钙化沉积物内的Vn、Tau和Ab的结构,
描述了驱动它们组装的蛋白质-矿物质相互作用。这些信息将是必不可少的,
了解钙化的分子机制,并最终开发新的诊断方法,
和治疗剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francesca M Marassi其他文献
Francesca M Marassi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francesca M Marassi', 18)}}的其他基金
Molecular mechanisms of calcification: roles and opportunities in diseases of aging
钙化的分子机制:在衰老疾病中的作用和机会
- 批准号:
10628925 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Membrane Protein Effectors of Pathogen Interactions With Host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
10630318 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
Membrane Protein Effectors of Pathogen Interactions With Host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
10207010 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
Membrane protein effectors of pathogen interactions with host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
9071833 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
Membrane Protein Effectors of Pathogen Interactions With Host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
10689583 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
Membrane protein effectors of pathogen interactions with host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
9276714 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
Membrane Protein Effectors of Pathogen Interactions With Host
病原体与宿主相互作用的膜蛋白效应子
- 批准号:
10404547 - 财政年份:2016
- 资助金额:
$ 63.79万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 63.79万 - 项目类别:
Continuing Grant